glp 1 kidney Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic disease through dampening the receptor for advanced glycation end products–induced inflammation GLP-1 and the kidney: from
Description
All of this hype comes from the rise in popularity of medications like Ozempic and Wegovy
10.2337/db23-127-OR 77.Wilson JM, Nikooienejad A, Robins DA, et al
[DOI] [PubMed] [Google Scholar] 92.Coskun T, et al
Approval of tirzepatide (brand name Mounjaro/Zepbound), an even more efficacious medication, soon followed in 2023
Indication 19.8.7
Clinical Oversight & Safety There is no named medical director on Sheds site
